BKKPF yields 4.52% · JNJ yields 2.13%● Live data
📍 BKKPF pulled ahead of the other in Year 1
Combined, BKKPF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BKKPF + JNJ for your $10,000?
Bangkok Bank Public Company Limited provides various commercial banking products and services in Thailand and internationally. The company operates through Domestic Banking, International Banking, Investment Banking, and Others segments. It offers various personal banking products and services, including savings, current, fixed deposit, foreign currency, and other accounts; home and personal loans, as well as loans for pensioners; mutual funds; investments products and services, such as bonds and debentures, as well as agency services; life and non-life bancassurance products; payment, funds transfer, currency exchange and foreign instrument, and SMS services; debit, credit, and prepaid cards; and phone and Internet banking, mobile banking, ATMs, and other services. The company also provides business banking products and services comprising operating accounts; loans for SMEs, international trade, investment banking, and e-guarantee services; securities services, such as custodian, mutual fund supervisor, provident fund registrar, securities registrar, and debenture holders' representative services; personal loans for small businesses; payment, collection, and merchant services; digital banking services; and commercial cards. In addition, it offers trade finance, remittances, export and import, project, corporate finance, and financial advisory services, as well as liquidity, fund, and asset management services. Bangkok Bank Public Company Limited was founded in 1944 and is headquartered in Bangkok, Thailand.
Full BKKPF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.